260 related articles for article (PubMed ID: 1890361)
1. A clinical, immunological, and histological study of neuritic leprosy patients.
Kaur G; Girdhar BK; Girdhar A; Malaviya GN; Mukherjee A; Sengupta U; Desikan KV
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):385-91. PubMed ID: 1890361
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic efficacy of cutaneous nerve biopsy in primary neuritic leprosy.
Jacob M; Mathai R
Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):56-60. PubMed ID: 3373086
[TBL] [Abstract][Full Text] [Related]
3. A clinico-pathological study of primary neuritic leprosy.
Pannikar VK; Arunthathi S; Chacko CJ; Fritschi EP
Lepr India; 1983 Apr; 55(2):212-21. PubMed ID: 6632781
[TBL] [Abstract][Full Text] [Related]
4. Histological changes in the nerve, skin and nasal mucosa of patients with primary neuritic leprosy.
Suneetha S; Arunthathi S; Kurian N; Chacko CJ
Acta Leprol; 2000-2001; 12(1):11-8. PubMed ID: 11526636
[TBL] [Abstract][Full Text] [Related]
5. Viability of Mycobacterium leprae in skin and peripheral nerves and persistence of nerve destruction in multibacillary patients after 2 years of multidrug therapy.
Job CK; Jayakumar J; Aschhoff M; Mathan MM
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):44-50. PubMed ID: 8627112
[TBL] [Abstract][Full Text] [Related]
6. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115
[TBL] [Abstract][Full Text] [Related]
7. Clinical and histopathological observations on pure neuritic leprosy.
Uplekar MW; Antia NH
Indian J Lepr; 1986; 58(4):513-21. PubMed ID: 3572092
[TBL] [Abstract][Full Text] [Related]
8. [Neurological manifestations of leprosy].
Grimaud J; Vallat JM
Rev Neurol (Paris); 2003 Nov; 159(11):979-95. PubMed ID: 14710019
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
[TBL] [Abstract][Full Text] [Related]
10. Local nerve damage in leprosy does not lead to an impaired cellular immune response or decreased wound healing in the skin.
Siddiqui MR; Moreira AL; Negesse Y; Taye GA; Hanekom WA; Haslett PA; Britton S; Kaplan G
J Infect Dis; 2002 Jul; 186(2):260-5. PubMed ID: 12134264
[TBL] [Abstract][Full Text] [Related]
11. Classification of nerves is modified by the delayed recognition of Mycobacterium leprae.
Ridley DS; Ridley MJ
Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):596-606. PubMed ID: 3546549
[TBL] [Abstract][Full Text] [Related]
12. Sub-clinical infection with Mycobacterium leprae in household contacts of leprosy.
Bhatia VN; Dhandayuthapani S; Ananthan D; Rajendran M; Vasanth B; Jayasingh K; Kumar CH
Indian J Lepr; 1990; 62(3):296-304. PubMed ID: 2262713
[TBL] [Abstract][Full Text] [Related]
13. Correlation of clinical, histological and immunological features across the leprosy spectrum.
Narayan NP; Ramu G; Desikan KV; Vallishayee RS
Indian J Lepr; 2001; 73(4):329-42. PubMed ID: 11898465
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of gene probes and its correlation with clinical profile of leprosy in children.
Dayal R; Agarwal PK; Kalra K; Bharadwaj VP; Katoch VM; Katoch K
Indian Pediatr; 1994 Dec; 31(12):1521-7. PubMed ID: 7875812
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the immune deficit in leprosy patients and the effect of recombinant IL-2 in vitro.
Locniskar M; McEniry DW; Mudd DW; Rose P; Lucas DC; Larrick J; McAdam KP
Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):249-60. PubMed ID: 3298472
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic evidence to show that indeterminate leprosy may be a primary lesion of the disease.
Job CK; Baskaran B; Jayakumar J; Aschhoff M
Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):443-9. PubMed ID: 9465152
[TBL] [Abstract][Full Text] [Related]
17. A quantitative study of the relationship between systemic and histological parameters of immunity in individual leprosy patients.
Cree IA; Smith WC; Beck JS
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):347-52. PubMed ID: 2198317
[TBL] [Abstract][Full Text] [Related]
18. Neuritic leprosy: further progression and significance.
Mishra B; Mukherjee A; Girdhar A; Husain S; Malaviya GN; Girdhar BK
Acta Leprol; 1995; 9(4):187-94. PubMed ID: 8711979
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiological immunological studies on leprosy in Okinawa. 6. Lepromin, lymphocyte transformation, FLA-ABS and leproagglutination tests in the in-and out-patients with leprosy and the relationships among these tests and personal or family history or clinical findings of the patients].
Minagawa F; Yoshino Y; Abe M; Saito N; Ohsawa Y; Ozawa T; Saikawa K
Nihon Rai Gakkai Zasshi; 1989; 58(2):92-111. PubMed ID: 2697714
[TBL] [Abstract][Full Text] [Related]
20. Reactions in borderline leprosy.
Ramu G; Desikan KV
Indian J Lepr; 2002; 74(2):115-28. PubMed ID: 12708730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
